Key Points
- Maverick Capital Ltd, a director of Infleqtion, sold 1,797,637 shares on May 29 for about $28.94 million at an average price of $16.10. This follows additional large insider sales earlier in the week, suggesting ongoing trimming by insiders.
- Infleqtion’s stock was down 9.1% and opened at $16.15, with a market cap of $3.52 billion. The company also reported a quarterly loss of $0.83 per share in its last earnings release.
- Analysts remain mixed but mostly constructive, with several Buy ratings and a consensus price target of $21.00. At the same time, recent headlines point to growth catalysts like a UK expansion, a planned threefold capacity increase, and possible U.S. government investment interest.
Infleqtion (NYSE:INFQ - Get Free Report) Director Maverick Capital Ltd sold 1,797,637 shares of the firm's stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $16.10, for a total transaction of $28,941,955.70. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Maverick Capital Ltd also recently made the following trade(s):
- On Friday, May 22nd, Maverick Capital Ltd sold 5,323,111 shares of Infleqtion stock. The shares were sold at an average price of $16.77, for a total transaction of $89,268,571.47.
- On Thursday, May 21st, Maverick Capital Ltd sold 6,584,519 shares of Infleqtion stock. The shares were sold at an average price of $14.69, for a total transaction of $96,726,584.11.
Infleqtion Trading Down 9.1%
NYSE INFQ opened at $16.15 on Friday. Infleqtion has a 12 month low of $8.52 and a 12 month high of $27.50. The company has a market cap of $3.52 billion and a P/E ratio of -179.39.
Infleqtion (NYSE:INFQ - Get Free Report) last posted its quarterly earnings data on Tuesday, March 31st. The quantum tech company reported ($0.83) EPS for the quarter.
Analysts Set New Price Targets
A number of research firms recently commented on INFQ. UBS Group began coverage on shares of Infleqtion in a research note on Wednesday, April 29th. They set a "buy" rating on the stock. BTIG Research began coverage on shares of Infleqtion in a report on Friday, April 10th. They set a "buy" rating and a $22.00 target price for the company. Weiss Ratings began coverage on shares of Infleqtion in a report on Wednesday. They set a "sell (d)" rating for the company. Wall Street Zen upgraded shares of Infleqtion from a "sell" rating to a "hold" rating in a report on Saturday. Finally, Citigroup began coverage on shares of Infleqtion in a report on Tuesday, April 14th. They set a "buy" rating and a $20.00 target price for the company. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $21.00.
Read Our Latest Analysis on Infleqtion
Key Headlines Impacting Infleqtion
Here are the key news stories impacting Infleqtion this week:
- Positive Sentiment: Infleqtion announced a major expansion of its UK quantum operations with a new Oxford Innovation Centre and manufacturing hub, which supports its long-term growth and capacity story. Article Title
- Positive Sentiment: Market commentary also highlighted Infleqtion’s plan to expand production capacity by threefold, which investors are reading as a signal of expected demand growth. Article Title
- Positive Sentiment: Reports that the U.S. government may invest up to $100 million in Infleqtion and other quantum names have boosted sentiment around the sector and validated the company’s strategic importance. Article Title
- Neutral Sentiment: Wall Street remains generally constructive, with several Buy ratings and an average price target near $21, though the stock remains volatile. Article Title
- Negative Sentiment: Large insider sales are a key overhang, including Director David B. Singer’s multimillion-share disposals and CEO Matthew John Kinsella’s repeated sales, which may be pressuring the stock. Article Title
- Negative Sentiment: More recent filings show CRO Paul Lipman sold 100,000 shares, adding to concerns that insiders are trimming exposure after the recent rally. Article Title
Infleqtion Company Profile
(
Get Free Report)
We are a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
